Otsuka Pharmaceutical Co., Ltd (TYO: 4578), abbreviated OPC, is a pharmaceutical company ... Otsuka's subsidiary Otsuka America will pay $100 million upfront for Neurovance, plus up-to $150 million in development and approval milestones ...
Otsuka in the U.S. From a family business to a global pharmaceutical business. Research and development of new pharmaceutical products and Digital Medicine. Fulfil your ... Otsuka Pharmaceutical Development & Commercialization, Inc.
Otsuka America Pharmaceutical, Inc. (OAPI) brings new medicines to market. OAPI commercializes Otsuka-developed and in-licensed products for use in ...
Otsuka in the U.S. has two companies that carry out research, clinical development and commercialization of ... Otsuka America Pharmaceutical, Inc. ( OAPI).
Otsuka in the U.S. offers a wide variety of careers in pharma. Examples of ... Otsuka Pharmaceutical Development & Commercialization, Inc. 508 Carnegie ...
Otsuka America Pharmaceutical, Inc. 2440 Research Blvd, Rockville ... Contact@ otsuka-us.com. Otsuka Pharmaceutical Development & Commercialization, Inc.
Corporate Headquarters/General Inquiries. Otsuka America Pharmaceutical, Inc. Rockville, MD 20850 USA (301) 990-0030 phone; (800) 562-3974 toll free
About us. There are two Otsuka pharmaceutical industry companies in the U.S.: Otsuka America Pharmaceutical, Inc. (OAPI) successfully commercializes ...
For almost 100 years, Otsuka has been committed to creating innovative ... Otsuka has created a global presence in the pharmaceutical, nutraceutical, and ...